Saturday, September 23, 2023
Saturday, September 23, 2023
Saturday, September 23, 2023

US Chamber of Commerce Challenges Government’s Drug Pricing Authority




Sign up with Your Content for the latest updates. Have a story or news tip? Contact our 24/7 newsroom at 833.336.8013 or email us.

The U.S. Chamber of Commerce has taken legal action against the federal government, filing a lawsuit to contest a recent law granting Medicare the ability to negotiate drug prices with pharmaceutical companies, Your Content has learned.

The chamber argues that this pricing program infringes upon drugmakers’ due process rights, as it grants the government unrestricted power to dictate maximum prices. Furthermore, the program’s harsh penalties for non-compliance essentially coerce drugmakers into accepting government-set prices.

The U.S. Department of Health and Human Services, responsible for administering Medicare, has yet to provide a comment in response to the lawsuit.

This lawsuit, brought forth by one of the most influential U.S. business organizations, follows a similar legal challenge filed by Merck & Co three days prior in Washington, D.C.

Both lawsuits contend that implementing price controls will hinder the development of new drugs, thereby adversely affecting Americans’ health in the long run. Various other pharmaceutical companies have voiced objections to this pricing program, which forms a part of the Inflation Reduction Act passed last year.

- Advertisement -

Any pricing changes resulting from CMS-led negotiations on ten high-cost drugs will be enforced in 2026.

It is a well-known fact that Americans pay higher prices for prescription drugs compared to any other country. The Biden administration aims to save $25 billion annually by 2031 through Medicare’s negotiation of drug prices.

White House spokeswoman Karine Jean-Pierre expressed confidence in winning the Merck case, stating that there is no constitutional barrier preventing Medicare from engaging in such negotiations.

The chamber additionally cautioned that allowing the pricing program would establish an unfavorable precedent.

Neil Bradley, Chief Policy Officer, stated, “If the government can impose price controls in the pharmaceutical industry, why not elsewhere?” This case has been assigned the title Dayton Area Chamber of Commerce et al v Becerra et al and is pending in the U.S. District Court, Southern District of Ohio, under the case number 23-00156, according to U.S. News.

Your Content for the latest updates. Have a story or news tip? Contact our 24/7 newsroom at 833.336.8013 or e-mail our tip line: [email protected]

Your Content is a publication centered around breaking news, trends, and true crime investigations. Sign up to receive our biggest stories as soon as they’re published.

Sen. Bob Menendez, Wife Indicted: Bribery Allegations Emerge Again

U.S. attorney for the Southern District of New York, Damian Williams, has unveiled an indictment against Sen. Bob Menendez (D-NJ) and his wife, Nadine Menendez, over bribery allegations, marking a significant turn of events for the chairman of the Senate Foreign Relations Committee.

Tommy Boyd, Fugitive Inmate, Seized Near Dierbergs Storefront

Tommy Wayne Boyd, the inmate who escaped from Mercy Hospital South in St. Louis, was apprehended near a Dierbergs on Watson Road in Shrewsbury.

Jacksonville Sheriff Searches for Escaped Inmate Gianna J. Ludd

The Jacksonville Sheriff’s Office has launched a manhunt for Gianna J. Ludd, 27, an escaped prisoner last seen in the 7000 block of Lorain Street.

Search Intensifies: Ronald Aveta, 85, Vanishes from Wantage Township

The New Jersey State Police Missing Persons Unit is actively searching for Ronald Aveta, 85, who went missing from Wantage Township, N.J., and are now seeking the public's assistance in the case.